Modernize Lung Cancer Diagnosis and Treatment with Viz.ai

Delays in diagnosis, testing, and appropriate treatment increase the risk of advanced-stage lung disease and higher mortality rates. It’s time to break this cycle and prioritize action. Picture a streamlined future where every patient receives timely screening, detection, NGS/PDL1 testing, and optimal treatment. We’re here to bridge the gaps in the patient journey and ensure no one falls through the cracks.

Enable Early Detection and Follow-up

• AI-powered detection for timely screening and diagnosis to improve patient outcomes
• Automated follow-up mechanisms upon detection or imaging results to notify all members of the care team to ensure next-best-action

Accelerate Biomarker Testing

• Notify oncologist and care team to facilitate NGS & PDL1 testing at time of diagnosis to accelerate and optimize patient treatment options

Case study: FDA-cleared Viz Aneurysm software automatically detects suspected cerebral aneurysms and triages patients for proper monitoring and treatment.